Heparin-induced antibodies and cardiovascular risk in patients on dialysis
1. 系统已在2025-10-21 16:48:55对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
LM Asmis, JB Segal, LC Plantinga…
… and haemostasis, 2008
thieme-connect.com
The clinical relevance of heparin-induced antibodies (HIA) in the absence of thrombocytopenia remains to be defined. The aims of this study were (i) to determine the prevalence of HIA in patients treated by dialysis,(ii) to determine the prevalence of thrombocytopenia and heparin-induced thrombocytopenia (HIT), and (iii) to test whether HIA are associated with adverse outcomes. Sera from 740 patients treated by hemodialysis (HD, n= 596) and peritoneal dialysis (PD, n= 144) were tested for HIA (IgG, IgA or IgM) by masked …
